logo

Neurology Research International

Neurology Research International / 2013 / Article / Tab 2

Research Article

Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics

Table 2

Classification of MS medication types.
First generation disease modifying drugs Interferons
Glatiramer acetate
Second generation disease modifying drugsAlemtuzumab
Cladribine
Daclizumab
Dimethyl fumarate
Fingolimod
Laquinimod
Rituximab
Teriflunomide
Natalizumab
Chemotherapy or immunosuppressants Azathioprine
Cyclophosphamide
Methotrexate
Mitoxantrone
Mycophenolate mofetil
IVIG or plasmapheresis Immunoglobulins IVIG
Plasmapheresis
Generic drugs Low-dose naltrexone
Minocycline
SteroidsAdrenocorticotropic hormone
Prednisolone
Symptom modifying drugsBaclofen
Fampridine

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.